1. Home
  2. HCAI vs ADIL Comparison

HCAI vs ADIL Comparison

Compare HCAI & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HCAI

Huachen AI Parking Management Technology Holding Co. Ltd. Ordinary Shares

HOLD

Current Price

$7.15

Market Cap

6.3M

ML Signal

HOLD

Logo Adial Pharmaceuticals Inc

ADIL

Adial Pharmaceuticals Inc

HOLD

Current Price

$1.58

Market Cap

6.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HCAI
ADIL
Founded
2004
2010
Country
China
United States
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3M
6.4M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
HCAI
ADIL
Price
$7.15
$1.58
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$37.50
AVG Volume (30 Days)
14.8M
91.3K
Earning Date
05-23-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$63.07
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.13
$0.13
52 Week High
$10.60
$3.67

Technical Indicators

Market Signals
Indicator
HCAI
ADIL
Relative Strength Index (RSI) 63.11 43.46
Support Level $0.41 $1.56
Resistance Level $8.75 $1.89
Average True Range (ATR) 1.10 0.09
MACD 0.44 0.00
Stochastic Oscillator 69.71 28.55

Price Performance

Historical Comparison
HCAI
ADIL

About HCAI Huachen AI Parking Management Technology Holding Co. Ltd. Ordinary Shares

Huachen AI Parking Management Technology Holding Co Ltd is a comprehensive smart parking solutions and equipment structural parts provider. The company manufactures and offer various cubic parking garage products by employing various working principles, such as lifting and shifting, convenient lifting, vertical circulation, vertical lifting, plane moving, alley stacking, multi-layer cycle, horizontal cycle, and car lift.

About ADIL Adial Pharmaceuticals Inc

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.

Share on Social Networks: